News ListThursday March 04, 2010 Ipsogen appoints Corinne Danan as Vice President Commercial OperationsIPSOGEN announces today that Corinne Danan has joined the company as Vice President Commercial Operations to develop Ipsogen presence in Europe and rest of the world.More Category: Corporate
 Tuesday December 08, 2009 IPSOGEN strengthens its Management and Board of DirectorsMarseille, 8th December 2009 - IPSOGEN (Alternext - FR0010626028 - ALIPS), a molecular diagnostic company that develops, manufactures and markets tests for leukemia and breast cancer, today announces changes in its board and... Category: Corporate, Investors
 Monday February 02, 2009 Next Events and Congresses (S1 2009)Ipsogen is participating to a great number of international congresses. Ipsogen’s team will be happy to meet you and discuss your current needs and find out about Ipsogen’s latest developments.In the Life Science Business... Category: Corporate
Monday January 26, 2009 Ipsogen appoints Hélène Peyro-Saint-Paul as Chief Medical OfficerMarseille, France, January 26, 2009 - IPSOGEN SA (Alternext - FR0010626028 - ALIPS), a molecular diagnostic company specialized in the development, production and commercialization of diagnostic assays for breast cancer and... Category: Corporate
Tuesday September 02, 2008 Ipsogen S.A consolidates its position in North America and appoints Susan Hertzberg President, Ipsogen IncSusan’s broad commercial experience and deep knowledge of the IVD and laboratory services sectors is a great advantage to expand Ipsogen’s presence in North America and around the world.Marseille, France, September 1st,... Category: Corporate, Investors
Monday September 01, 2008 Ipsogen expands its sales forceAfter the success of its recent IPO, Ipsogen is committed to strengthen its commercial operations worldwide. In this perspective, Ipsogen recently started a targeted recruitment campaign. By joining Ipsogen, you will actively... Category: Corporate
Monday October 29, 2007 IPSOGEN facilities certified ISO13485 for IVDIPSOGEN, a leading molecular diagnostic company based in France and Connecticut, today announced that its headquarters in Marseille, France, have received ISO (International Standards Organization) 13485:2003.ISO 13485 is an... Category: Corporate
Tuesday August 28, 2007 Affymetrix and IPSOGEN Collaborate to Develop and Market In-Vitro Diagnostic Cancer TestsMARSEILLE, France and SANTA CLARA, Calif., August 28, 2007 – Affymetrix Inc. (Nasdaq: AFFX) and IPSOGEN, a leading molecular diagnostic company based in France and Connecticut, today announced that they have signed a Powered by... Category: Corporate
Tuesday August 14, 2007 Ipsogen grants Warnex exclusive rights, for the Canadian territory, to market a service for the diagnosis and the classification of a group of leukemiasIpsogen SAS. today announced the signature of an exclusive agreement with Warnex Inc. (TSX: WNX), a life sciences company devoted to protecting public health by providing laboratory services to the pharmaceutical and healthcare... Category: Corporate
Tuesday August 07, 2007 Ipsogen expands and opens New Haven office to market its leukaemia molecular diagnostic products in North AmericaIpsogen, Inc., founded in March 2005 as a subsidiary of Ipsogen SAS, a leading provider of molecular diagnostics in oncology headquartered in Marseille, France, today announced the opening of its new facilities in New Haven,... Category: Corporate
|
|
